OpenAlex
PricingAboutJobs
Log inGet started
Work

Combination of EGFR and MEK1/2 inhibitor shows synergistic effects by suppressing EGFR/HER3-dependent AKT activation in human gastric cancer cells

HTML

Year: 2009
Type: article
Source: Molecular Cancer Therapeutics
DOI: 10.1158/1535-7163.mct-09-0300
Authors: Young-Kwang Yoon, Hwang-Phill Kim, Sae-Won Han, Hyung-Seok Hur, Do Youn Oh, Seock-Ah Im, Yung-Jue Bang, Tae-You Kim
Institution: Seoul National University
Language: English

Topic: Melanoma and MAPK Pathways
Subfield: Molecular Biology
Field: Biochemistry, Genetics and Molecular Biology
Domain: Life Sciences
Keywords: EGFR tyrosine kinase inhibitors, MEK inhibitors, gastric cancer, HER3, Akt activation, PI3K signaling, KRAS mutation, drug synergy, drug resistance, selumetinib, combination therapy, pathway crosstalk
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2158971458
FWCI: 2.542
Cites: 44
Cited by: 77
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security